Questioning Medicine

Episode 320: 319. President Biden has COVID, Should the First Lady Take Paxlovid?

Informações:

Sinopsis

https://www.nejm.org/doi/full/10.1056/NEJMoa2309002In this placebo-controlled trial, postexposure prophylaxis with nirmatrelvir–ritonavir for 5 or 10 days did not significantly reduce the risk of symptomatic SARS-CoV-2 infection.https://www.nejm.org/doi/full/10.1056/NEJMoa2309003https://www.nejm.org/doi/full/10.1056/NEJMoa2118542Pfizer has some serious problems! #pfizer